2005
DOI: 10.1016/j.bbamcr.2004.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Effector-induced Syk-mediated phosphorylation in human erythrocytes

Abstract: Band 3 (AE1), the most prominent polypeptide of the human erythrocyte membrane, becomes heavily tyrosine phosphorylated following treatment of intact cells with protein tyrosine phosphatase inhibitors such as diamide, pervanadate, vanadate, or N-ethylmaleimide (NEM). The mechanism underlying this tyrosine phosphorylation is thought to involve the sequential action of two protein tyrosine kinases, Syk (p72syk) and Lyn (p53/56lyn). While Lyn catalysed phosphorylation appears to be strictly dependent on prior pho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
53
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(59 citation statements)
references
References 31 publications
6
53
0
Order By: Relevance
“…In diseased red cells, we observed an increase of band 3 tyrosine phosphorylation, most likely due to increased membrane association of Syk and Lyn kinases which have already been reported to tyrosine-phosphorylate band 3. [30][31][32] In addition, changes in the tyrosinephosphorylation of band 4.1, band 4.2, and stomatin were evident in diseased red cells and were independent of the adaptive mechanisms to cell swelling ( Figure 5), suggesting a perturbation of intracellular signaling pathways toward the membrane-cytoskeleton network. 22,[33][34][35] Previous studies in skate red cells have shown that volume expansion is associated with increased Syk and Lyn activity and changes in phosphorylation state of various membrane proteins and in their association with membrane lipid rafts.…”
Section: Discussionmentioning
confidence: 99%
“…In diseased red cells, we observed an increase of band 3 tyrosine phosphorylation, most likely due to increased membrane association of Syk and Lyn kinases which have already been reported to tyrosine-phosphorylate band 3. [30][31][32] In addition, changes in the tyrosinephosphorylation of band 4.1, band 4.2, and stomatin were evident in diseased red cells and were independent of the adaptive mechanisms to cell swelling ( Figure 5), suggesting a perturbation of intracellular signaling pathways toward the membrane-cytoskeleton network. 22,[33][34][35] Previous studies in skate red cells have shown that volume expansion is associated with increased Syk and Lyn activity and changes in phosphorylation state of various membrane proteins and in their association with membrane lipid rafts.…”
Section: Discussionmentioning
confidence: 99%
“…Syk kinase has been widely studied as a therapeutic target in inflammation [59], neurodegenerative disorders [60], allergy [61] and cancer [62][63][64]. Besides the studies performed in erythrocytes [26,27,65], the role of cysteine oxidation on Syk activity and functions in T cells are still unknown.…”
Section: Introductionmentioning
confidence: 99%
“…We recently demonstrated that diamide-treated erythrocytes express a well-defined tyrosine phosphorylation (Tyr-P) level of membrane proteins, particularly of band 3 (20). Alterations in band 3 Tyr-P levels represent preexisting modifications of membrane status, like that observed in glucose-6-phosphate dehydrogenase (G6PD)-deficient patients (18,21) suffering from chronic impairment of antioxidant defenses or in endometriotic women (22) with systemic inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…Alterations in band 3 Tyr-P levels represent preexisting modifications of membrane status, like that observed in glucose-6-phosphate dehydrogenase (G6PD)-deficient patients (18,21) suffering from chronic impairment of antioxidant defenses or in endometriotic women (22) with systemic inflammation. Diamide, a mild oxidant, affects the sulfhydryl groups of cysteines by inducing disulfide bond formation and triggers band 3 Tyr-P (16,17,18,20,21,22), which is a useful parameter in the evaluation of oxidation-related damage to cells (18,21,22). We also observed that, while diamide treatment reduced total glutathione (GSH) contents detectable in the cytosol of endometriotic patients, normal subjects were unaffected, and the differences between GSH content before and after diamide treatment were defined as DGSH, an additional parameter of inflammatory status in endometriosis (22).…”
Section: Introductionmentioning
confidence: 99%